VMD Relaxes Restrictions on Flunixin in Response to Vet Pressure
BEVA has welcomed the news that the Veterinary Medicines Directorate (VMD) has relaxed its recently imposed restrictions on the sale of the essential equine pain killer flunixin by allowing the release of stock from manufacturers.
British Equine Veterinary Association
Stock of flunixin held by manufacturers will be distributed alongside a 'caution in use' letter that will explain the restricted use of this product.
BEVA has welcomed the news that the Veterinary Medicines Directorate (VMD) has relaxed its recently imposed restrictions on the sale of the essential equine pain killer flunixin by allowing the release of stock from manufacturers. This action will, in the short term, restore access to this medicine for use in non-food producing horses.
Jon Pycock, BEVA president, noted, "It remains a concern to BEVA that this mechanism was not put in place before the suspension of flunixin was imposed. Contrary to assertions by the VMD, wholesalers were unable to meet the demands of the veterinary profession and clinical use of this medicine was disrupted within 24 hours of the VMD's initial announcement. We are surprised by the Regulator's lack of awareness of availability in the supply chain and question why there was no consultation with the veterinary sector before the suspension was enacted. The VMD has been aware of this issue since March 2018, and it appears that no contingency was put in place to consider the animal welfare impact of this decision until it was too late."
BEVA Junior Vice President and Specialist in Equine Surgery Tim Mair continued: "Flunixin is a unique medicine in managing pain and sepsis in horses with colic. The VMD appeared to believe that this medicine could be substituted for other veterinary medicines, and this is simply not the case. The release of stock from manufacturers is a short-term solution and, looking forward, we would like assurances that the VMD will fast track applications for the modification of product licenses to ensure that equine vets have continued access to these products."
Professor Kate White, Senior Vice President of the Association of Veterinary Anaesthetists, added: "provision of pain relief is essential to maintain animal welfare. The loss of these products would hinder the work of vets working with horses and donkeys and in zoos where they are first-line drugs for the management of pain. Use of flunixin in these animals can be undertaken safely with no impact on human health."
Stock of flunixin held by manufacturers will be distributed alongside a 'caution in use' letter that will explain the restricted use of this product. BEVA is reminding all equine vets that the horse's food chain status must be checked when using this product—either using the paper passport or the recently launched chip checker on the central equine database website.
British VMD Allows Sale Of Flunixin For Non-food Animals Due To Veterinary Pressure 2018
BEVA Urges VMD to Overturn Suspension of Flunixin
The British Equine Veterinary Associaion (BEVA) is calling on the VMD to immediately enable limited batch release of flunixin for use in horses not destined for the human food chain in the interests of animal welfare.
BEVA Launches Online Dental Resources to Support Vets and Guide Owners
The British Equine Veterinary Association (BEVA) has launched a new section on its website to help veterinarians and horse owners better understand equine dentistry.
BEVA Launches 'Don't Break Your Vet' Campaign
Equine veterinarians have one of the highest injury risk of all civilian professions. To help address this serious issue, the British Equine Veterinary Association (BEVA) has launched a campaign to encourage horse owners to help reduce the risks that vets sometimes face.
Join the World's Equine Vets at BEVA Congress
Registration is now open and the full program is available for Europe's largest equine veterinary conference.
BEVA Launches Fundamentals Programme to Support New Equine Vets
The series of 10 courses covers the essentials of equine care to equip those who are keen to establish themselves in equine practice with the essential skills they need to carry out their day job.
2019 BEVA Congress Final Day Theme on Sport Horses
Keeping the sport horse on the road will be the theme for the final day at this year's BEVA Congress held September 11-14.
British Vets and Horse Owners Please Sign Up for the National Equine Health Survey
You owe it to your horse to take equine health seriously, and that's why it's so important for British veterinarians and horse owners to take part in the next National Equine Health Survey (NEHS), which is being held May 21–28, 2018.
BEVA Congress Introduces Crèche Facilities
For the first time, BEVA Congress will be providing crèche facilities for working Mums and Dads needing childcare for their children.
BEVA Congress to Address Non-Clinical Duties of Equine Veterinarians
The 2018 BEVA Congress, which runs September 12-15, contains a wealth of sessions on succession planning as well as practice finance, human resources and marketing.